Targeting folate receptor alpha for cancer treatment

Promising targeted treatments and immunotherapy strategies in oncology and advancements in our understanding of molecular pathways that underpin cancer development have reignited interest in the tumor-associated antigen Folate Receptor alpha (FRα). FRα is a glycosylphosphatidylinositol (GPI)-anchore...

Descripción completa

Detalles Bibliográficos
Autores principales: Cheung, Anthony, Bax, Heather J., Josephs, Debra H., Ilieva, Kristina M., Pellizzari, Giulia, Opzoomer, James, Bloomfield, Jacinta, Fittall, Matthew, Grigoriadis, Anita, Figini, Mariangela, Canevari, Silvana, Spicer, James F., Tutt, Andrew N., Karagiannis, Sophia N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5239573/
https://www.ncbi.nlm.nih.gov/pubmed/27248175
http://dx.doi.org/10.18632/oncotarget.9651

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5239573/
https://www.ncbi.nlm.nih.gov/pubmed/27248175
http://dx.doi.org/10.18632/oncotarget.9651

Ejemplares similares